Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inovio Pharmaceuticals Inc. (NasdaqGS: INO).
On March 9, 2020 Citron Research published a statement highlighting the Company’s “ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours” and calling for an SEC investigation into the claims. That same day, the Company disclosed that its purported COVID-19 vaccine, which had been developed “within three hours,” was not a fully-fledged vaccine at all, but merely a construct for a vaccine.
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.
KSF’s investigation is focusing on whether Inovio’s officers and/or directors breached their fiduciary duties to Inovio’s shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Inovio shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (email@example.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ino/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Lewis Kahn, Managing Partner